Strategic Milestone Achievement and Increased Financial Discipline Underscore Year of Corporate Transformation Completed ...

Morgan Stanley raised the firm’s price target on BioNTech (BNTX) to $140 from $139 and keeps an Overweight rating on the shares. The firm ...

Vetter, Chairman of the Supervisory Board of ITM. " The expansion of our Supervisory Board and its insights ensures that ITM ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $139.00.

BioNTech SE ( ($BNTX) ) has shared an update. On April 4, 2025, BioNTech SE announced the invitation to its Annual General Meeting scheduled for ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

US biotech Novavax (Nasdaq: NVAX) is still waiting on a decision from the Food and Drug Administration over full approval of its protein-based COVID-19 vaccine, despite the agency having set an April ...

Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 20.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The ...

Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 36.1% during the fourth quarter, according to its most recent Form ...

BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...